A National Phase IV Study With Ipilimumab for Patients With Advanced Malignant Melanoma.
NCT02068196
·
clinicaltrials.gov ↗
PHASE4
Phase
ACTIVE_NOT_RECRUITING
Status
150
Enrollment
OTHER
Sponsor class
Conditions
Malignant Melanoma
Interventions
PROCEDURE:
Blood sampling for Pre-existing immunity
DRUG:
Ipilimumab
Sponsor
Oslo University Hospital